Target intelligence / Profile preview

Endogenous cellular poly-tailed small RNAs

Molecular classification
RNA, Small RNA, Ligand
01

Overview

Endogenous cellular poly-tailed small RNAs are a diverse group of RNA molecules characterized by a 3' polyadenosine (poly(A)) tail and often a 5' triphosphate moiety. These RNAs are typically generated as byproducts of RNA metabolism or through the action of non-canonical poly(A) polymerases like TENT4A and TENT4B, which mark them for degradation or stabilization. They function as potent endogenous ligands for the cytosolic sensor RIG-I (Retinoic acid-inducible gene I), which triggers the innate immune system's antiviral response. Under normal physiological conditions, these RNAs are sequestered or rapidly degraded to prevent autoimmunity; however, their accumulation can lead to chronic inflammation or interferonopathies. While they are not traditional therapeutic targets, their role in RIG-I activation makes them significant in the study of autoimmune diseases and the development of synthetic RNA-based immunotherapies for cancer.

Other names
Polyadenylated small RNAsPoly(A) small RNAs5'-triphosphate polyadenylated RNAsEndogenous RIG-I ligands
02

Mechanism of action

Binding and activation of the RIG-I receptor, leading to MAVS-mediated induction of type I interferons and proinflammatory cytokines.

03

Biological functions

Innate immune activationPattern recognition receptor signalingRNA stability regulationInterferon induction
04

Disease associations

Autoimmune diseaseViral infectionCancerInflammation
05

Safety considerations

Systemic inflammationCytokine release syndromeAutoimmune activation
06

Biomarkers

Cytoplasmic poly(A) RNA levelsType I interferon signatureRIG-I activation state

Beyond the preview

Go deeper on Endogenous cellular poly-tailed small RNAs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endogenous cellular poly-tailed small RNAs.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call